Management of Hypertensive Urgency

Limitations of Hydralazine

The American College of Cardiology recommends against using hydralazine as a first-line agent for hypertensive urgency due to its unpredictable blood pressure response, prolonged duration of action, and inability to titrate effectively 1, 2
Hydralazine has a variable magnitude of blood pressure reduction, making safe blood pressure control difficult, with a response that begins within 10-30 minutes but cannot be reliably predicted 1, 2, 3
The hypotensive effect of hydralazine lasts 2-4 hours, creating a risk of excessive blood pressure lowering without the ability to reverse it 1, 3
Hydralazine is not titratable, unlike continuous infusions, and is given as bolus doses that cannot be adjusted once administered 1, 2

The American College of Cardiology and American Heart Association guidelines state that hydralazine's unpredictability of response and prolonged duration of action do not make it a desirable first-line agent for acute treatment in most patients 1, 2

The European Society of Hypertension defines hypertensive urgency as severe blood pressure elevation (>180/120 mmHg) without acute target organ damage 6
The goal of management is to gradually reduce blood pressure over 24-48 hours using oral agents, with a target reduction of no more than 25% within the first hour, then to 160/100 mmHg over the next 2-6 hours if stable 6

The American College of Cardiology recommends nicardipine, clevidipine, and labetalol as preferred alternatives for hypertensive emergencies, with specific dosing regimens for each 1, 5
Nicardipine can be initiated at 5 mg/h IV and increased by 2.5 mg/h every 5 minutes to a maximum of 15 mg/h, and is easily titratable 1, 5
Clevidipine can be initiated at 1-2 mg/h IV and doubled every 90 seconds until blood pressure approaches target, and is ultra-short acting 1, 5
Labetalol can be given at 0.3-1.0 mg/kg (maximum 20 mg) slow IV every 10 minutes, but is contraindicated with bradycardia, heart block, or reactive airway disease 1, 5

The American Heart Association recommends hydralazine for eclampsia/preeclampsia, with a dosing regimen of 5-10 mg IV bolus initially, then 5-10 mg IV every 20-30 minutes as needed, maximum 25 mg 2, 4
Alternative obstetric dosing for hydralazine is 10 mg slow IV infusion (maximum initial dose 20 mg), repeated every 4-6 hours 1, 6